Strengthening the Community-Based Home Healthcare Network
First written in FY2016. 8 of 12 entries say "Advanced", first in FY2019. Latest entry: FY2026.
0 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the consolidated fiscal year under review, the Group made capital expenditures and other investments totaling ¥19,205 million, primarily in rental assets such as home-use oxygen concentrators and the rebuilding of the Shirai facility. The required funds were financed entirely with internal funds.」
Capital expenditures of ¥19,205 million were made, primarily for rental assets such as home-use oxygen concentrators and the rebuilding of the Shirai facility. Investment increased from ¥12,496 million in the previous fiscal year. - FY2025AdvancedAnnual report
「During the consolidated fiscal year under review, the Group made capital expenditures and other investments totaling ¥12,496 million, primarily in rental assets such as home-use oxygen concentrators and the rebuilding of the Shirai facility. The required funds were financed entirely with internal funds.」
Capital expenditures of ¥12,496 million were made, primarily for rental assets such as home-use oxygen concentrators and the rebuilding of the Shirai facility. - FY2024AdvancedAnnual report
「During the consolidated fiscal year under review, the Group made capital expenditures and other investments totaling ¥14,895 million, primarily in rental assets such as home-use oxygen concentrators. The required funds were financed entirely with internal funds.」
Capital expenditures of ¥14,895 million were made, primarily for rental assets such as home-use oxygen concentrators and the rebuilding of the Shirai facility. Investment increased from ¥11,140 million in the previous fiscal year. - FY2023AdvancedAnnual report
「During the consolidated fiscal year under review, the Group made capital expenditures and other investments totaling ¥11,140 million, primarily in rental assets such as home-use oxygen concentrators. The required funds were financed entirely with internal funds.」
Capital expenditures of ¥11,140 million were made, primarily for rental assets such as home-use oxygen concentrators. - FY2022AdvancedAnnual report
「The Group made capital investments and other investments of ¥13,799 million during the fiscal year, mainly in rental assets such as home-use oxygen concentrators and the rebuilding of the head office building.」
Capital expenditures of ¥13,799 million were made, primarily for rental assets such as home-use oxygen concentrators and the rebuilding of the head office building. - FY2021AdvancedAnnual report
「The Group made capital investments and other investments of ¥11,435 million during the fiscal year, mainly in rental assets such as home-use oxygen concentrators and the rebuilding of the head office building.」
The company made ¥11,435 million in capital investments, mainly in rental assets such as home-use oxygen concentrators and the rebuilding of the head office building. - FY2020AdvancedAnnual report
「The Group made capital investments and other investments of ¥12,426 million during the fiscal year, mainly in rental assets such as home-use oxygen concentrators and the rebuilding of the head office building.」
The company made ¥12,426 million in capital investments, mainly in rental assets such as home-use oxygen concentrators. - FY2019AdvancedAnnual report
「The Group made capital investments and other investments of ¥7,940 million during the fiscal year, mainly in rental assets such as home-use oxygen concentrators.」
The company made ¥7,940 million in capital investments, mainly in rental assets for home healthcare, particularly home-use oxygen concentrators. - FY2018RestatedAnnual report
「Through strategic investment in fields expected to grow and effective R&D initiatives, we will work to deliver comprehensive proposals to medical institutions and strengthen the community-based structure in home healthcare.」
The company reiterates its policy of strengthening the community-based structure in home healthcare through strategic investment and R&D. - FY2017RestatedAnnual report
「Through strategic investment in fields expected to grow and effective R&D initiatives, we will work to deliver comprehensive proposals to medical institutions and strengthen the community-based structure in home healthcare.」
The company reiterates its policy of strengthening the community-based structure in home healthcare through investment and R&D in growth fields. - FY2017-Q3RestatedAnnual report
「The business alliance will enable the creation of a new home healthcare business by combining FUKUDA DENSHI CO.,LTD.'s home healthcare services, including home oxygen therapy and CPAP, with Omron Healthcare Co., Ltd.'s advanced blood pressure measurement technology and wearable medical devices developed using its miniaturization technology.」
The company reiterates its concept for a new home healthcare business combining home oxygen therapy, CPAP, blood pressure measurement technology, and wearable medical devices. - FY2016First statedAnnual report
「We will work to strengthen the community-based structure in the home healthcare field.」
The company describes this as a measure to strengthen its community-based structure in home healthcare.